| KLAMOVÁ, Hana, Daniela ŽÁČKOVÁ, Edgar FABER, Katerina STEINEROVA, Michal KARAS, Eva DEMECKOVA, Jaroslava VOGLOVÁ, Ludmila DEMITROVICOVA, Elena TOTHOVA, Juraj CHUDEJ, Imrich MARKULJAK, Tomas KOZAK, Eduard CMUNT, Marie JAROSOVA, Katerina MACHOVA-POLAKOVA, Kyra MICHALOVA, Ladislav DUŠEK, Jan MUŽÍK, Martin MISTRIK, Jiří MAYER, Marek TRNENY a Karel INDRAK. The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009. In 52nd Annual meeting ASH in Blood. 2010. ISSN 0006-4971. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{920937,
author = {Klamová, Hana and Žáčková, Daniela and Faber, Edgar and Steinerova, Katerina and Karas, Michal and Demeckova, Eva and Voglová, Jaroslava and Demitrovicova, Ludmila and Tothova, Elena and Chudej, Juraj and Markuljak, Imrich and Kozak, Tomas and Cmunt, Eduard and Jarosova, Marie and MachovaandPolakova, Katerina and Michalova, Kyra and Dušek, Ladislav and Mužík, Jan and Mistrik, Martin and Mayer, Jiří and Trneny, Marek and Indrak, Karel},
booktitle = {52nd Annual meeting ASH in Blood},
language = {cze},
title = {The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.},
year = {2010}
}
TY - CONF
ID - 920937
AU - Klamová, Hana - Žáčková, Daniela - Faber, Edgar - Steinerova, Katerina - Karas, Michal - Demeckova, Eva - Voglová, Jaroslava - Demitrovicova, Ludmila - Tothova, Elena - Chudej, Juraj - Markuljak, Imrich - Kozak, Tomas - Cmunt, Eduard - Jarosova, Marie - Machova-Polakova, Katerina - Michalova, Kyra - Dušek, Ladislav - Mužík, Jan - Mistrik, Martin - Mayer, Jiří - Trneny, Marek - Indrak, Karel
PY - 2010
TI - The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.
ER -
KLAMOVÁ, Hana, Daniela ŽÁČKOVÁ, Edgar FABER, Katerina STEINEROVA, Michal KARAS, Eva DEMECKOVA, Jaroslava VOGLOVÁ, Ludmila DEMITROVICOVA, Elena TOTHOVA, Juraj CHUDEJ, Imrich MARKULJAK, Tomas KOZAK, Eduard CMUNT, Marie JAROSOVA, Katerina MACHOVA-POLAKOVA, Kyra MICHALOVA, Ladislav DUŠEK, Jan MUŽÍK, Martin MISTRIK, Jiří MAYER, Marek TRNENY a Karel INDRAK. The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009. In \textit{52nd Annual meeting ASH in Blood}. 2010. ISSN~0006-4971.
|
